Reviva Pharmaceuticals (RVPH) Q2 2025 Earnings

May 15Confirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-0.38
-0.29
-0.21
-0.13

Details

Expected EPS
-0.1971
Actual EPS
-0.13
Surprise EPS
0.07
Surprise Percent
+34.04%

Description

⁨Reviva Pharmaceuticals⁩ (⁦RVPH⁩) has reported earnings of ⁦-0.13⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts